PharmaShots | Incisive News in 3 Shots

Subscribe Now

Liquidia Corporation

Liquidia Corporation’s Yutrepia Receives the US FDA’s Tentative Approval to Treat PAH & PH-ILD

Liquidia Corporation’s Yutrepia Receives the US FDA’s Tentative Approval to Treat PAH & PH-ILD

August 21, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us